First UK Patients to Use New Psoriasis Treatment Report Huge Improvements
The first British patients to use Soratinex, a treatment for psoriasis that does not contain potentially-harmful steroids, say their symptoms have reduced by an average of 79 per cent during the 12 months it has been on sale in the UK.
Psoriasis sufferers responding to a survey to co-incide with first anniversary of the treatment’s release also say their quality of life has improved by an average 73 per cent.
The three-part treatment, a gel, oil and cream, was launched in Britain following clinical trials in London in which six out of 10 patients enjoyed reductions in their symptoms of between 51 and 100 per cent.
In the latest survey:
* Asked to rate their satisfaction levels with Soratinex between 1 and 100 per cent, the average response was 81 per cent.
* 74 per cent of respondents said they experienced an improvement in their symptoms in the first three weeks of using Soratinex.
* Asked whether they would prefer to use a treatment with or without steroids, 95 per cent opted for steroid-free.
* Asked whether they would recommend the treatment to other sufferers, 90 per cent said they would.
* Invited to use a word of their own choosing to describe Soratinex, the top five words chosen were: ‘Excellent’, ‘Brilliant’, ‘Amazing’, ‘Fantastic’ and ‘Effective’.
The average improvement in quality of life – 73 per cent, according to respondents – is particularly significant as, when asked whether their psoriasis had ever led to depression, almost 68 per cent said it had.
‘These results are very satisfying and show that our first year in the UK has been a great success,’ said Judith Kovacs, CEO of FRANKL Pharma, the European distributor of Soratinex. ‘It is good to know we are improving the lives of so many people. Let’s hope we can help many more in the future.’
Psoriasis is an auto-immune condition that speeds up the skin replacement process, meaning cells that normally take 21 to 28 days to replace are actually produced in a few days. This build-up of cells results in raised ‘plaques’ which can become inflamed, flaky and painful . It can occur on all parts of the body.
Almost 2 million people in the UK suffer from the condition.